Gene Therapy Market Size, Share, And Growth Report 2032

Gene Therapy Market

Gene Therapy Market by Type (Somatic Cell Gene Therapy and Germ Cell Gene Therapy), by Application (Genetic Disorders, Cancer, Cardiovascular Disease, and Others), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3218 Published Date: Aug-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 8.86 Billion USD 41.40 Billion 18.68% 2023

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global gene therapy market, 2017 - 2024 (USD Million)
    • 2.2. Global gene therapy market: Snapshot
  •  
  • Chapter 3. Gene Therapy Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global gene therapy market drivers: Impact analysis
      • 3.2.2. The increasing prevalence of genetic disorders and other lifestyle-related life-threatening diseases across the globe
      • 3.2.3. Rising need for gene therapy based targeted treatment
    • 3.3. Market Restraints
      • 3.3.1. Global Gene therapy market restraints: Impact analysis
      • 3.3.2. Need for an individual case-by-case approach
    • 3.4. Opportunities
      • 3.4.1. Increasing adoption of personalized medicines
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by type
      • 3.6.2. Market attractiveness analysis, by application
      • 3.6.3. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Gene Therapy Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global gene therapy market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Gene Therapy Market - Type Analysis
    • 5.1. Global gene therapy market: Type overview
      • 5.1.1. Global gene therapy market revenue share, by Type, 2017 and 2024
    • 5.2. Somatic cell gene therapy
      • 5.2.1. Global gene therapy market for Somatic cell gene therapy, 2017 - 2024 (USD Million)
    • 5.3. Germ cell gene therapy
      • 5.3.1. Global gene therapy market for Germ Cell Gene Therapy, 2017 - 2024 (USD Million)
  •  
  • Chapter 6. Global Gene Therapy Market - Application Analysis
    • 6.1. Global gene therapy market: Application overview
      • 6.1.1. Global gene therapy market revenue share, by Application, 2017 and 2024
    • 6.2. Genetic Disorders
      • 6.2.1. Global gene therapy market for genetic disorders, 2017 - 2024 (USD Million)
    • 6.3. Cancer
      • 6.3.1. Global gene therapy market for Cancer, 2017 - 2024 (USD Million)
    • 6.4. Cardiovascular Disease
      • 6.4.1. Global gene therapy market for Cardiovascular Disease, 2017 - 2024 (USD Million)
    • 6.5. Other Diseases
      • 6.5.1. Global gene therapy market for other diseases, 2017 - 2024 (USD Million)
  •  
  • Chapter 7. Global Gene Therapy Market - Regional Analysis
    • 7.1. Global gene therapy market: Regional overview
      • 7.1.1. Global gene therapy market revenue share, by region, 2017 and 2024
    • 7.2. North America
      • 7.2.1. North America gene therapy market revenue, by type, 2017 - 2024 (USD Million)
      • 7.2.2. North America gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.2.3. The U.S.
        • 7.2.3.1. The U.S. gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.2.3.2. The U.S. gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.2.4. Canada
        • 7.2.4.1. Canada gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.2.4.2. Canada gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.2.5.2. Rest of North America gene therapy market revenue, by application, 2017 - 2024 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe gene therapy market revenue, by type, 2017 - 2024 (USD Million)
      • 7.3.2. Europe gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.3.3. U.K.
        • 7.3.3.1. U.K. gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.3.3.2. U.K. gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.3.4. Germany
        • 7.3.4.1. Germany gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.3.4.2. Germany gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.3.5.2. France gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.3.6. Italy
        • 7.3.6.1. Italy gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.3.6.2. Italy gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.3.7. Spain
        • 7.3.7.1. Spain gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.3.7.2. Spain gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.3.8. Russia
        • 7.3.8.1. Russia gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.3.8.2. Russia gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.3.9. Rest of Europe
        • 7.3.9.1. Rest of Europe gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.3.9.2. Rest of Europe gene therapy market revenue, by application, 2017 - 2024 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific gene therapy market revenue, by type, 2017 - 2024 (USD Million)
      • 7.4.2. Asia Pacific gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.4.3. China
        • 7.4.3.1. China gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.4.3.2. China gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.4.4. Japan
        • 7.4.4.1. Japan gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.4.4.2. Japan gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.4.5. India
        • 7.4.5.1. India gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.4.5.2. India gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.4.6. Australia
        • 7.4.6.1. Australia gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.4.6.2. Australia gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.4.7.2. Rest of Asia Pacific gene therapy market revenue, by application, 2017 - 2024 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America gene therapy market revenue, by type, 2017 - 2024(USD Million)
      • 7.5.2. Latin America gene therapy market revenue, by application, 2017 - 2024(USD Million)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.5.3.2. Brazil gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.5.4. Mexico
        • 7.5.4.1. Mexico gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.5.4.2. Mexico gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.5.5. Argentina
        • 7.5.5.1. Argentina gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.5.5.2. Argentina gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.5.6. Rest of Latin America
        • 7.5.6.1. Rest of Latin America gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.5.6.2. Rest of Latin America gene therapy market revenue, by application, 2017 - 2024 (USD Million)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa gene therapy market revenue, by type, 2017 - 2024 (USD Million)
      • 7.6.2. The Middle East and Africa gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.6.3. Saudi Arabia
        • 7.6.3.1. Saudi Arabia gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.6.3.2. Saudi Arabia gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.6.4. UAE
        • 7.6.4.1. UAE gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.6.4.2. UAE gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.6.5. South Africa
        • 7.6.5.1. South Africa gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.6.5.2. South Africa gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.6.6. Qatar
        • 7.6.6.1. Qatar gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.6.6.2. Qatar gene therapy market revenue, by application, 2017 - 2024 (USD Million)
      • 7.6.7. Rest of the Middle East and Africa
        • 7.6.7.1. Rest of the Middle East and Africa gene therapy market revenue, by type, 2017 - 2024 (USD Million)
        • 7.6.7.2. Rest of the Middle East and Africa gene therapy market revenue, by application, 2017 - 2024 (USD Million)
  •  
  • Chapter 8. Company Profile
    • 8.1. UniQure N.V
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Therapy portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Spark Therapeutics LLC
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Therapy portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Bluebird Bio
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Therapy portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Juno Therapeutics
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Therapy portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. GlaxoSmithKline
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Therapy portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Celgene Corporation
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Therapy portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Shire Plc
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Therapy portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Sangamo Biosciences
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Therapy portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global gene therapy market revenue, 2017 – 2024 (USD Million) 
4. Porter’s five forces analysis
5. Gene therapy Market attractiveness analysis, by type
6. Gene therapy: Market attractiveness analysis, by application
7. Gene therapy: Market attractiveness analysis, by regional
8. Company market share analysis, 2017
9. Global gene therapy market revenue share by type, 2017 and 2024
10. Global gene therapy market for somatic cell gene therapy, 2017 – 2024 (USD Million)
11. Global gene therapy market for germ cell gene therapy, 2017 – 2024 (USD Million)
12. Global gene therapy market revenue share by application, 2017 and 2024
13. Global gene therapy market for genetic disorders, 2017 – 2024 (USD Million)
14. Global gene therapy market for cancer, 2017 – 2024 (USD Million)
15. Global gene therapy market for cardiovascular disease, 2017 – 2024 (USD Million)
16. Global gene therapy market for other diseases, 2017 – 2024 (USD Million)
17. North America gene therapy market, 2017 - 2024 (USD Million)
18. Europe gene therapy market, 2017 - 2024 (USD Million)
19. Asia Pacific gene therapy market, 2017 - 2024 (USD Million)
20. Latin America gene therapy market, 2017 - 2024 (USD Million)
21. The Middle East and Africa gene therapy market, 2017 - 2024 (USD Million)


Table Of Tables

List of Tables

1. Gene therapy market: Market Snapshot                                                            
2. Drivers of global gene therapy market: Impact analysis 
3. Restraints of global gene therapy market: Impact analysis 
4. North America gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
5. North America gene therapy market revenue, by application, 2017 – 2024 (USD Million)
6. U.S. gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
7. U.S. gene therapy market revenue, by application, 2017 – 2024 (USD Million)
8. Canada gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
9. Canada gene therapy market revenue, by application, 2017 – 2024 (USD Million)
10. Rest of North America gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
11. Rest of North America gene therapy market revenue, by application, 2017 – 2024 (USD Million)
12. Europe gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
13. Europe gene therapy market revenue, by application, 2017 – 2024 (USD Million)
14. U.K. gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
15. U.K. gene therapy market revenue, by application, 2017 – 2024 (USD Million)
16. Germany gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
17. Germany gene therapy market revenue, by application, 2017 – 2024 (USD Million)
18. France gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
19. France gene therapy market revenue, by application, 2017 – 2024 (USD Million)
20. Italy gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
21. Italy gene therapy market revenue, by application, 2017 – 2024 (USD Million)
22. Spain gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
23. Spain gene therapy market revenue, by application, 2017 – 2024 (USD Million)
24. Russia gene therapy market revenue, by type, 2017 – 2024 (USD Million)
25. Russia gene therapy market revenue, by application, 2017 – 2024 (USD Million)
26. Rest of Europe gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
27. Rest of Europe gene therapy market revenue, by application, 2017 – 2024 (USD Million)
28. Asia Pacific gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
29. Asia Pacific gene therapy market revenue, by application, 2017 – 2024 (USD Million)
30. China gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
31. China gene therapy market revenue, by application, 2017 – 2024 (USD Million)
32. Japan gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
33. Japan gene therapy market revenue, by application, 2017 – 2024 (USD Million)
34. India gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
35. India gene therapy market revenue, by application, 2017 – 2024 (USD Million)
36. Australia gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
37. Australia gene therapy market revenue, by application, 2017 – 2024 (USD Million)
38. Rest of Asia Pacific gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
39. Rest of Asia Pacific gene therapy market revenue, by application, 2017 – 2024 (USD Million)
40. Latin America gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
41. Latin America gene therapy market revenue, by application, 2017 – 2024 (USD Million)
42. Brazil gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
43. Brazil gene therapy market revenue, by application, 2017 – 2024 (USD Million)
44. Mexico gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
45. Mexico gene therapy market revenue, by application, 2017 – 2024 (USD Million)
46. Argentina gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
47. Argentina gene therapy market revenue, by application, 2017 – 2024 (USD Million)
48. Rest of Latin America gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
49. Rest of Latin America gene therapy market revenue, by application, 2017 – 2024 (USD Million)
50. The Middle East and Africa gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
51. The Middle East and Africa gene therapy market revenue, by application, 2017 – 2024 (USD Million)
52. Saudi Arabia gene therapy revenue, by type, 2017 – 2024 (USD Million) 
53. Saudi Arabia gene therapy market revenue, by application, 2017 – 2024 (USD Million)
54. UAE gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
55. UAE gene therapy market revenue, by application, 2017 – 2024(USD Million)
56. South Africa gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
57. South Africa gene therapy market revenue, by application, 2017 – 2024 (USD Million)
58. Qatar gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
59. Qatar gene therapy market revenue, by application, 2017 – 2024 (USD Million)
60. Rest of the Middle East and Africa gene therapy market revenue, by type, 2017 – 2024 (USD Million) 
61. Rest of the Middle East and Africa gene therapy market revenue, by application, 2017 – 2024 (USD Million)

Methodology

FrequentlyAsked Questions

Gene therapy is the process where a DNA is inserted into a patient to treat a specific disease. The DNA is carefully selected to correct the effect of a mutated gene. Gene therapy is suitable for treating cancer by destroying a certain group of cells.

According to study, the Gene Therapy Market size was worth around USD 8.86 billion in 2023 and is predicted to grow to around USD 41.40 billion by 2032.

The CAGR value of Gene Therapy Market is expected to be around 18.68% during 2024-2032.

North America has been leading the Gene Therapy Market and is anticipated to continue on the dominant position in the years to come.

The Gene Therapy Market is led by players like UniQure N.V, Spark Therapeutics LLC, Bluebird Bio, Juno Therapeutics, GlaxoSmithKline, Celgene Corporation, Shire Plc, Sangamo Biosciences, Dimension Therapeutics, Voyager Therapeutics, Human Stem Cell Institute, Bristol Myer’s Squibb, and Chiesi Farmaceutici S.p.A., among others.

  • zion payment modes

List of Contents

SizeOverviewSegmentationReport ScopeRegional AnalysisCompetitive PlayersThe Global Market is segmented as follows:

HappyClients